QQQ   348.82 (-1.70%)
AAPL   177.82 (-0.78%)
MSFT   323.38 (-3.09%)
META   263.60 (-2.77%)
GOOGL   122.50 (-3.78%)
AMZN   121.23 (-4.25%)
TSLA   224.57 (+1.47%)
NVDA   374.75 (-3.05%)
NIO   7.76 (-1.52%)
BABA   85.29 (-1.63%)
AMD   117.83 (-5.15%)
T   16.09 (+2.68%)
F   13.59 (+5.11%)
MU   67.06 (-0.71%)
CGC   0.72 (-2.69%)
GE   106.08 (+0.59%)
DIS   92.53 (+0.40%)
AMC   4.73 (+1.94%)
PFE   38.89 (+1.36%)
PYPL   64.04 (-1.51%)
NFLX   399.77 (+0.12%)
QQQ   348.82 (-1.70%)
AAPL   177.82 (-0.78%)
MSFT   323.38 (-3.09%)
META   263.60 (-2.77%)
GOOGL   122.50 (-3.78%)
AMZN   121.23 (-4.25%)
TSLA   224.57 (+1.47%)
NVDA   374.75 (-3.05%)
NIO   7.76 (-1.52%)
BABA   85.29 (-1.63%)
AMD   117.83 (-5.15%)
T   16.09 (+2.68%)
F   13.59 (+5.11%)
MU   67.06 (-0.71%)
CGC   0.72 (-2.69%)
GE   106.08 (+0.59%)
DIS   92.53 (+0.40%)
AMC   4.73 (+1.94%)
PFE   38.89 (+1.36%)
PYPL   64.04 (-1.51%)
NFLX   399.77 (+0.12%)
QQQ   348.82 (-1.70%)
AAPL   177.82 (-0.78%)
MSFT   323.38 (-3.09%)
META   263.60 (-2.77%)
GOOGL   122.50 (-3.78%)
AMZN   121.23 (-4.25%)
TSLA   224.57 (+1.47%)
NVDA   374.75 (-3.05%)
NIO   7.76 (-1.52%)
BABA   85.29 (-1.63%)
AMD   117.83 (-5.15%)
T   16.09 (+2.68%)
F   13.59 (+5.11%)
MU   67.06 (-0.71%)
CGC   0.72 (-2.69%)
GE   106.08 (+0.59%)
DIS   92.53 (+0.40%)
AMC   4.73 (+1.94%)
PFE   38.89 (+1.36%)
PYPL   64.04 (-1.51%)
NFLX   399.77 (+0.12%)
QQQ   348.82 (-1.70%)
AAPL   177.82 (-0.78%)
MSFT   323.38 (-3.09%)
META   263.60 (-2.77%)
GOOGL   122.50 (-3.78%)
AMZN   121.23 (-4.25%)
TSLA   224.57 (+1.47%)
NVDA   374.75 (-3.05%)
NIO   7.76 (-1.52%)
BABA   85.29 (-1.63%)
AMD   117.83 (-5.15%)
T   16.09 (+2.68%)
F   13.59 (+5.11%)
MU   67.06 (-0.71%)
CGC   0.72 (-2.69%)
GE   106.08 (+0.59%)
DIS   92.53 (+0.40%)
AMC   4.73 (+1.94%)
PFE   38.89 (+1.36%)
PYPL   64.04 (-1.51%)
NFLX   399.77 (+0.12%)
NASDAQ:ATLC

Atlanticus (ATLC) Stock Forecast, Price & News

$39.21
+1.14 (+2.99%)
(As of 06/7/2023 ET)
Compare
Today's Range
$38.26
$39.58
50-Day Range
$26.63
$38.07
52-Week Range
$21.65
$42.66
Volume
27,570 shs
Average Volume
18,950 shs
Market Capitalization
$566.98 million
P/E Ratio
7.95
Dividend Yield
N/A
Price Target
$46.00

Atlanticus MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
17.3% Upside
$46.00 Price Target
Short Interest
Bearish
9.55% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Selling Shares
$73,775 Sold Last Quarter
Proj. Earnings Growth
13.00%
From $5.00 to $5.65 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.90 out of 5 stars

Finance Sector

676th out of 852 stocks

Personal Credit Institutions Industry

10th out of 13 stocks


ATLC stock logo

About Atlanticus (NASDAQ:ATLC) Stock

Atlanticus Holdings Corp. is a financial holding company, which engages in the provision of financial technology and related services. It operates through the Credit as a Service (CaaS) and Auto Finance segments. The CaaS segment includes private label credit and general purpose credit cards originated by lenders through multiple channels, including retail and healthcare, direct mail solicitation, digital marketing and partnerships with third parties. The Auto Finance segment services loans secured by independent automotive dealers and automotive finance companies in the buy-here, pay-here used car business. The company was founded by David G. Hanna in August 1996 and is headquartered in Atlanta, GA.

Receive ATLC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Atlanticus and its competitors with MarketBeat's FREE daily newsletter.

ATLC Stock News Headlines

Atlanticus (NASDAQ:ATLC) Shares Gap Up to $34.24
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
AT Lease SAE (ATLC)
Atlanticus (NASDAQ:ATLC) Upgraded by StockNews.com to "Buy"
Atlanticus Holdings Corp Preferred (ATLCP)
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
StockNews.com Downgrades Atlanticus (NASDAQ:ATLC) to Hold
Atlanticus (NASDAQ:ATLC) Lifted to "Buy" at StockNews.com
ATLC Atlanticus Holdings Corporation
ATLC.DF - | Stock Price & Latest News | Reuters
Visa Stock: Is It a Smart Investment This Week?
Are Investors Undervaluing Atlanticus (ATLC) Right Now?
Is Atlanticus (ATLC) Stock Undervalued Right Now?
Atlanticus Reports Third Quarter 2022 Financial Results
See More Headlines

ATLC Price History

ATLC Company Calendar

Last Earnings
3/14/2023
Today
6/07/2023
Next Earnings (Estimated)
8/08/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Personal credit institutions
Sub-Industry
N/A
Sector
Finance
Current Symbol
NASDAQ:ATLC
Employees
328
Year Founded
1996

Price Target and Rating

Average Stock Price Forecast
$46.00
High Stock Price Forecast
$50.00
Low Stock Price Forecast
$42.00
Forecasted Upside/Downside
+17.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$135.60 million
Pretax Margin
13.52%

Debt

Sales & Book Value

Annual Sales
$1.05 billion
Cash Flow
$10.92 per share
Book Value
$22.50 per share

Miscellaneous

Free Float
6,885,000
Market Cap
$566.98 million
Optionable
Optionable
Beta
1.70

Social Links


Key Executives

  • Jeffrey A. HowardJeffrey A. Howard
    President, Chief Executive Officer & Director
  • William R. McCamey
    Chief Financial Officer
  • Linda Brooks
    Chief Technology Officer
  • Rosalind Drakeford
    Secretary & Chief Compliance Officer
  • Mitchell C. Saunders
    Chief Accounting Officer













ATLC Stock - Frequently Asked Questions

Should I buy or sell Atlanticus stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Atlanticus in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" ATLC shares.
View ATLC analyst ratings
or view top-rated stocks.

What is Atlanticus' stock price forecast for 2023?

2 brokers have issued 1-year price objectives for Atlanticus' shares. Their ATLC share price forecasts range from $42.00 to $50.00. On average, they anticipate the company's share price to reach $46.00 in the next twelve months. This suggests a possible upside of 17.3% from the stock's current price.
View analysts price targets for ATLC
or view top-rated stocks among Wall Street analysts.

How have ATLC shares performed in 2023?

Atlanticus' stock was trading at $26.20 at the beginning of 2023. Since then, ATLC stock has increased by 49.7% and is now trading at $39.21.
View the best growth stocks for 2023 here
.

When is Atlanticus' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 8th 2023.
View our ATLC earnings forecast
.

How were Atlanticus' earnings last quarter?

Atlanticus Holdings Co. (NASDAQ:ATLC) announced its quarterly earnings results on Tuesday, March, 14th. The credit services provider reported $0.98 earnings per share (EPS) for the quarter. The credit services provider had revenue of $268.66 million for the quarter, compared to analyst estimates of $294.59 million. Atlanticus had a trailing twelve-month return on equity of 36.92% and a net margin of 10.83%.

What ETFs hold Atlanticus' stock?

ETFs with the largest weight of Atlanticus (NASDAQ:ATLC) stock in their portfolio include Royce Quant Small-Cap Quality Value ETF (SQLV),

What other stocks do shareholders of Atlanticus own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Atlanticus investors own include Energy Transfer (ET), ACADIA Pharmaceuticals (ACAD), Biocept (BIOC), Enterprise Products Partners (EPD), Inpixon (INPX), Inseego (INSG), Novavax (NVAX), Pfizer (PFE), AT&T (T) and Veru (VERU).

What is Atlanticus' stock symbol?

Atlanticus trades on the NASDAQ under the ticker symbol "ATLC."

Who are Atlanticus' major shareholders?

Atlanticus' stock is owned by a number of retail and institutional investors. Top institutional investors include Dimensional Fund Advisors LP (3.92%), BlackRock Inc. (2.23%), Renaissance Technologies LLC (0.88%), State Street Corp (0.67%), Geode Capital Management LLC (0.65%) and Bank of New York Mellon Corp (0.34%). Insiders that own company stock include David G Hanna, Deal W Hudson, Denise M Harrod, Dennis H James Jr, Jeffrey A Howard, Jeffrey A Howard, Joseph Christopher Hays, Mack F Mattingly, Mitchell Saunders, Thomas G Rosencrants and William Mccamey.
View institutional ownership trends
.

How do I buy shares of Atlanticus?

Shares of ATLC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Atlanticus' stock price today?

One share of ATLC stock can currently be purchased for approximately $39.21.

How much money does Atlanticus make?

Atlanticus (NASDAQ:ATLC) has a market capitalization of $566.98 million and generates $1.05 billion in revenue each year. The credit services provider earns $135.60 million in net income (profit) each year or $4.93 on an earnings per share basis.

How many employees does Atlanticus have?

The company employs 328 workers across the globe.

How can I contact Atlanticus?

Atlanticus' mailing address is FIVE CONCOURSE PARKWAY SUITE 300, ATLANTA GA, 30328. The official website for the company is www.atlanticus.com. The credit services provider can be reached via phone at (770) 828-2000, via email at investors@atlanticus.com, or via fax at 770-901-5859.

This page (NASDAQ:ATLC) was last updated on 6/7/2023 by MarketBeat.com Staff

My Account -